Navigation Links
Takeda Cares Day Raises $63,700

DEERFIELD, Ill., Sept. 20, 2013 /PRNewswire/ -- Takeda, a top 15 global pharmaceutical company, will raise money for local organizations today when employees participate in their third annual Takeda Cares Day event on the company's Deerfield campus.

More than 600 employees will run or walk a 5K course on the company's campus. Takeda will donate $100 for each employee who participates in the event to one of three community organizations that the participating employee has pre-selected. An estimated $63,700 will be raised. The event will also host speakers from the local community organizations.   

Takeda is a company that strives toward better health for people worldwide through leading innovation in medicine. This pursuit begins when employees participate in a culture of health through events like Takeda Cares Day. Further, the event recognizes employees' commitment to making a difference in the community through Takeda's corporate giving programs, many of which align with the company's three focus areas – health, science and community vitality.

Donation Recipients
In its third year, the event was created to advance Takeda's philanthropic commitment to the Chicagoland area and to promote employee camaraderie. This year's beneficiaries dedicate their time to the following causes:

  • HealthReach - A free medical clinic that provides a patient-centered medical home to 5,000 of the uninsured, underserved residents of Lake County, Ill.
  • Junior Achievement of Chicago - An educational nonprofit bringing financial literacy, work readiness and entrepreneurship programs into classrooms from kindergarten through high school.
  • R&D (STEM) Learning Exchange - Brings interested learners together with organizations that can provide unique opportunities in science, technology, engineering and math (STEM) education.

"By supporting HealthReach, Takeda is making an impact and changing the lives of the medically uninsured, providing them with high quality care where they are treated with dignity and respect," said Nancy Bock, Executive Director of HealthReach. "HealthReach is grateful for the support Takeda is providing toward our mission and the people we serve every day."

About Takeda in the Chicagoland Area
As a science and evidence-based company with a strong presence in Deerfield, Ill., Takeda is committed to contributing to the health of people worldwide and supporting the community and the environment. Takeda Pharmaceuticals U.S.A., Inc., and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market metabolic, gout, gastroenterology, and central nervous system treatments and seek to bring innovative products to patients. To learn more about these Takeda companies, visit


Kara Hoeger
Takeda Pharmaceuticals U.S.A, Inc.
(224) 554-1277

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):